학술논문
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
Document Type
Article
Author
Source
In: European Journal of Neurology . (European Journal of Neurology, September 2023, 30(9):2859-2864)
Subject
Language
English
ISSN
14681331
13515101
13515101